Novartis announced that oseltamivir phosphate granules have obtained a pharmaceutical registration certificate.
诺泰生物：磷酸奥司他韦颗粒获得药品注册证书
Novartis: Oseltamivir phosphate granules obtained pharmaceutical registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.